| Nicholas James Abbott, MD | |
|
19250 Sw 65th Ave, Tualatin, OR 97062-7452 | |
| (503) 413-7162 | |
| (503) 692-2101 |
| Full Name | Nicholas James Abbott |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 13 Years |
| Location | 19250 Sw 65th Ave, Tualatin, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124319330 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Legacy Emanuel Medical Center | Portland, OR | Hospital |
| Legacy Good Samaritan Medical Center | Portland, OR | Hospital |
| Legacy Mount Hood Medical Center | Gresham, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Clinics Llc | 0244144004 | 603 |
| Legacy Good Samaritan Hospital And Medical Center | 0547179939 | 128 |
| Legacy Mount Hood Medical Center | 3173515996 | 43 |
| Legacy Emanuel Hospital And Health Center | 4587573639 | 170 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today that Stephane Boissel, CEO, TxCell and other senior management will either attend, present to, and meet investors at a number of leading forthcoming investor conferences.
The number of specialty behavioral health establishments, their workforce and their wages have increased steadily between 2011 and 2019, according to a new study by Indiana University and University of Michigan researchers.
A new study published in the journal mBio focuses on the role of nasal bacteria in eliciting virus-specific adaptive immunity.
As the use of oral chemotherapy continues to rise, researchers from Michigan State University have discovered many patients fail to properly take the cancer-fighting medication, a significant clinical problem that can result in complications and premature death.
› Verified 2 days ago
| Entity Name | Legacy Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902827272 PECOS PAC ID: 0244144004 Enrollment ID: O20031117000089 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today that Stephane Boissel, CEO, TxCell and other senior management will either attend, present to, and meet investors at a number of leading forthcoming investor conferences.
The number of specialty behavioral health establishments, their workforce and their wages have increased steadily between 2011 and 2019, according to a new study by Indiana University and University of Michigan researchers.
A new study published in the journal mBio focuses on the role of nasal bacteria in eliciting virus-specific adaptive immunity.
As the use of oral chemotherapy continues to rise, researchers from Michigan State University have discovered many patients fail to properly take the cancer-fighting medication, a significant clinical problem that can result in complications and premature death.
› Verified 2 days ago
| Entity Name | Legacy Good Samaritan Hospital And Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780608216 PECOS PAC ID: 0547179939 Enrollment ID: O20031125000416 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today that Stephane Boissel, CEO, TxCell and other senior management will either attend, present to, and meet investors at a number of leading forthcoming investor conferences.
The number of specialty behavioral health establishments, their workforce and their wages have increased steadily between 2011 and 2019, according to a new study by Indiana University and University of Michigan researchers.
A new study published in the journal mBio focuses on the role of nasal bacteria in eliciting virus-specific adaptive immunity.
As the use of oral chemotherapy continues to rise, researchers from Michigan State University have discovered many patients fail to properly take the cancer-fighting medication, a significant clinical problem that can result in complications and premature death.
› Verified 2 days ago
| Entity Name | Legacy Emanuel Hospital & Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831112358 PECOS PAC ID: 4587573639 Enrollment ID: O20040127001204 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today that Stephane Boissel, CEO, TxCell and other senior management will either attend, present to, and meet investors at a number of leading forthcoming investor conferences.
The number of specialty behavioral health establishments, their workforce and their wages have increased steadily between 2011 and 2019, according to a new study by Indiana University and University of Michigan researchers.
A new study published in the journal mBio focuses on the role of nasal bacteria in eliciting virus-specific adaptive immunity.
As the use of oral chemotherapy continues to rise, researchers from Michigan State University have discovered many patients fail to properly take the cancer-fighting medication, a significant clinical problem that can result in complications and premature death.
› Verified 2 days ago
| Entity Name | Legacy Meridian Park Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184647620 PECOS PAC ID: 5092609842 Enrollment ID: O20040211001181 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today that Stephane Boissel, CEO, TxCell and other senior management will either attend, present to, and meet investors at a number of leading forthcoming investor conferences.
The number of specialty behavioral health establishments, their workforce and their wages have increased steadily between 2011 and 2019, according to a new study by Indiana University and University of Michigan researchers.
A new study published in the journal mBio focuses on the role of nasal bacteria in eliciting virus-specific adaptive immunity.
As the use of oral chemotherapy continues to rise, researchers from Michigan State University have discovered many patients fail to properly take the cancer-fighting medication, a significant clinical problem that can result in complications and premature death.
› Verified 2 days ago
| Entity Name | Legacy Mount Hood Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386919132 PECOS PAC ID: 3173515996 Enrollment ID: O20040401000550 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today that Stephane Boissel, CEO, TxCell and other senior management will either attend, present to, and meet investors at a number of leading forthcoming investor conferences.
The number of specialty behavioral health establishments, their workforce and their wages have increased steadily between 2011 and 2019, according to a new study by Indiana University and University of Michigan researchers.
A new study published in the journal mBio focuses on the role of nasal bacteria in eliciting virus-specific adaptive immunity.
As the use of oral chemotherapy continues to rise, researchers from Michigan State University have discovered many patients fail to properly take the cancer-fighting medication, a significant clinical problem that can result in complications and premature death.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas James Abbott, MD Po Box 3777, Portland, OR 97208-3777 Ph: (503) 413-3900 | Nicholas James Abbott, MD 19250 Sw 65th Ave, Tualatin, OR 97062-7452 Ph: (503) 413-7162 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today that Stephane Boissel, CEO, TxCell and other senior management will either attend, present to, and meet investors at a number of leading forthcoming investor conferences.
The number of specialty behavioral health establishments, their workforce and their wages have increased steadily between 2011 and 2019, according to a new study by Indiana University and University of Michigan researchers.
A new study published in the journal mBio focuses on the role of nasal bacteria in eliciting virus-specific adaptive immunity.
As the use of oral chemotherapy continues to rise, researchers from Michigan State University have discovered many patients fail to properly take the cancer-fighting medication, a significant clinical problem that can result in complications and premature death.
› Verified 2 days ago
Jaymee E Delaney, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 19260 Sw 65th Ave, Ste 270, Tualatin, OR 97062 Phone: 503-352-0770 | |
Jessica Kazue Haraga, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 19250 Sw 90th Ave, Tualatin, OR 97062 Phone: 503-692-3750 Fax: 503-691-2324 | |
Dr. Benito G Pataroque, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6485 Sw Borland Rd, Suite D, Tualatin, OR 97062 Phone: 503-692-3647 Fax: 503-691-1670 | |
Dr. Tammi Kaye Boston, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 19875 Sw 65th Ave, Suite 100, Tualatin, OR 97062 Phone: 503-692-7785 Fax: 503-885-1663 | |
Dr. William H Treuhaft, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 6485 Sw Borland Rd, Suite F, Tualatin, OR 97062 Phone: 503-413-3650 Fax: 503-413-3644 | |
Dean Kyle Peterson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 19300 Sw 65th Ave, Tualatin, OR 97062 Phone: 503-413-8407 Fax: 503-413-6951 | |
Dr. Mark Leo Mckinstry, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 19875 Sw 65th Ave, Tualatin, OR 97062 Phone: 503-692-7785 Fax: 503-885-1663 |